Cite

HARVARD Citation

    Hakami, O. et al. (2019). A case of pembrolizumab-induced severe DKA and hypothyroidism in a patient with metastatic melanoma. Endocrinology, diabetes & metabolism case reports. p. . [Online]. 
  
Back to record